RAPT Therapeutics stock falls after halting its zelnecirnon program following FDA clinical hold. Company shifts focus.

The featured speakers... at 08:30 U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial Novavax, Inc. , a global company advancing ...

We are pleased that these important results are now published in an impactful scientific journal," said Göran Forsberg, CEO of Cantargia ... Firm Investigates Claims On Behalf of Investors of Novavax, ...

A pair of inflation reports, the tail end of third-quarter earnings season, and an address from Federal Reserve Chair Jerome ...